Clinical trials: Peanut-Induced Anaphylaxis, open to volunteers
- Condition Peanut-Induced Anaphylaxis
- Status Open to volunteers
- Funder type Industry (pharma, biotech, devices)
Peanut-Induced Anaphylaxis, Peanut Allergy
UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies
This study will test a new investigational treatment called UKK-0018. UKK-0018 as an immunotherapeutic for the treatment of peanut allergies.
- Trial name
- UKK-0018 (NCT07349212)
- Testing
- UKK-0018
- Where
- 6 sites in Australia, New Zealand
- Volunteers
- 40 people
- Sponsor
- Ukko Inc